Search results
Shared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in children.
Nat Commun, 15(1):8224, 19 Sep 2024
Cited by: 0 articles | PMID: 39300098 | PMCID: PMC11413185
Add to export list
Free full text in Europe PMCKCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution.
Biol Methods Protoc, 9(1):bpae046, 20 Jun 2024
Cited by: 0 articles | PMID: 38993523 | PMCID: PMC11238426
Add to export list
Free full text in Europe PMCOpen Science at PLOS Pathogens.
PLoS Pathog, 19(11):e1011776, 30 Nov 2023
Cited by: 0 articles | PMID: 38033157 | PMCID: PMC10688847
Add to export list
Free full text in Europe PMCBroad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection.
mBio, 14(5):e0120623, 25 Sep 2023
Cited by: 3 articles | PMID: 37747187 | PMCID: PMC10653880
Add to export list
Free full text in Europe PMCThe effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort study.
EClinicalMedicine, 62:102086, 21 Jul 2023
Cited by: 22 articles | PMID: 37654669 | PMCID: PMC10466229
Add to export list
Free full text in Europe PMCCross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.
Mol Cell Proteomics, 22(8):100600, 19 Jun 2023
Cited by: 1 article | PMID: 37343697 | PMCID: PMC10279469
Add to export list
Free full text in Europe PMCThird-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders.
Blood Adv, 7(10):1954-1957, 01 May 2023
Cited by: 0 articles | PMID: 36083126 | PMCID: PMC9472701
Add to export list
Free full text in Europe PMCBroad and potent neutralizing mAbs are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
bioRxiv, 30 Mar 2023
Cited by: 0 articles | PPR: PPR638356
Add to export list Preprint
Free full text in Europe PMCThe effects of COVID-19 on cognitive performance in a community-based cohort: A COVID Symptom Study Biobank observational study
medRxiv, 19 Mar 2023
Cited by: 0 articles | PPR: PPR632897
Add to export list Preprint
Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein.
Nat Commun, 14(1):1421, 14 Mar 2023
Cited by: 19 articles | PMID: 36918534 | PMCID: PMC10013288
Add to export list
Free full text in Europe PMCLong-COVID fatigue is not predicted by pre-pandemic plasma IL-6 levels in mild COVID-19.
Inflamm Res, 72(5):947-953, 30 Mar 2023
Cited by: 2 articles | PMID: 36995412 | PMCID: PMC10062244
Add to export list
Free full text in Europe PMCAntibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Elife, 12:e80428, 24 Jan 2023
Cited by: 8 articles | PMID: 36692910 | PMCID: PMC9940912
Add to export list
Free full text in Europe PMCThe effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern.
PLoS Pathog, 18(10):e1010882, 03 Oct 2022
Cited by: 3 articles | PMID: 36191037 | PMCID: PMC9560610
Add to export list
Free full text in Europe PMCPre-Pandemic Plasma IL-6 Levels are Positively Associated with Chronic Fatigue But Do Not Differentiate Those with COVID-19 Induced Fatigue
SSRN, 17 Aug 2022
Cited by: 0 articles | PPR: PPR606999
Add to export list Preprint
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination.
Cell Rep, 40(8):111276, 11 Aug 2022
Cited by: 23 articles | PMID: 35981534 | PMCID: PMC9365860
Add to export list
Free full text in Europe PMCModular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2.
Mol Ther, 30(12):3639-3657, 10 Aug 2022
Cited by: 9 articles | PMID: 35949171 | PMCID: PMC9364715
Add to export list
Free full text in Europe PMCIndicators of recent COVID-19 infection status: findings from a large occupational cohort of staff and postgraduate research students from a UK university.
BMC Public Health, 22(1):1514, 09 Aug 2022
Cited by: 1 article | PMID: 35945541 | PMCID: PMC9363143
Add to export list
Free full text in Europe PMCThe effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
medRxiv, 05 Aug 2022
Cited by: 0 articles | PPR: PPR528968
Add to export list Preprint
Free full text in Europe PMCConcordance of B- and T-cell responses to SARS-CoV-2 infection, irrespective of symptoms suggestive of COVID-19.
J Med Virol, 94(11):5217-5224, 30 Jul 2022
Cited by: 5 articles | PMID: 35864567 | PMCID: PMC9349709
Add to export list
Free full text in Europe PMCMX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation.
mBio, 13(4):e0171422, 26 Jul 2022
Cited by: 5 articles | PMID: 35880880 | PMCID: PMC9426416
Add to export list
Free full text in Europe PMCDrug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2.
PLoS Comput Biol, 18(7):e1010330, 18 Jul 2022
Cited by: 6 articles | PMID: 35849631 | PMCID: PMC9333455
Add to export list
Free full text in Europe PMCACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19.
Int J Obes (Lond), 46(8):1478-1486, 20 May 2022
Cited by: 25 articles | PMID: 35589964 | PMCID: PMC9119844
Add to export list
Free full text in Europe PMCAntibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors
medRxiv, 22 May 2022
Cited by: 0 articles | PPR: PPR496809
Add to export list Preprint
Free full text in Europe PMCDistinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5
bioRxiv, 25 May 2022
Cited by: 0 articles | PPR: PPR498079
Add to export list Preprint
Free full text in Europe PMCImpaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib.
Blood Cancer J, 12(4):73, 22 Apr 2022
Cited by: 7 articles | PMID: 35459222 | PMCID: PMC9024068
Add to export list
Free full text in Europe PMC
Follow us
Partnerships & funding
Europe PMC is developed by EMBL-EBI with support from the Europe PMC Funders' Group, in collaboration with the National Library of Medicine (NLM), as part of the PubMed Central International archive network.
Europe PMC is an ELIXIR Core Data Resource, Global Core Biodata Resource, and conforms with EMBL-EBI’s long term data preservation policies.